FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount ...

The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing ( discussing the 340B program and its growth and impacts on patients.

A discount drug program is being abused by large hospital chains in Chicago leaving communities on the South and West sides ...

A bipartisan group of senators is working to draft legislation to reform a fast-growing hospital drug discount program designed to help low-income patients.

But when it comes to the federal 340B Drug Pricing Program, recent legislative efforts to expand it — through House Bill 276 ...

The 340B Drug Pricing Program (the Program) has long been a cornerstone for healthcare providers seeking to deliver affordable care to underserved communities. However, as the regulatory and ...

The 340B Drug Pricing Program is a federal lifeline for vulnerable and underserved communities across the U.S., and its importance in Orlando is profound. Created to allow health-care safety-net ...

The Health Resources and Services Administration has sent a letter to Johnson & Johnson warning the company of the consequences if it proceeds with its planned 340B rebate proposal. In a Sept. 17 ...

On August 6, 2025, the U.S. Court of Appeals for the Second Circuit issued an opinion allowing a case challenging drug pricing changes to proceed. The case, an antitrust action brought by health ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.